医学
循环肿瘤DNA
循环肿瘤细胞
生物标志物
肿瘤科
内科学
液体活检
癌症研究
肿瘤进展
DNA
化疗
转移
癌症
远处转移
病理
作者
Dekuang Zhao,Vaseem M. Khatri,Justyn Y. Nakashima,Juskaran S. Chadha,Monica Sheila Chatwal,Jingsong Zhang,Filip Ionescu,Joshua A. Linscott,Roger Li,Michael Adam Poch,Wade Jeffers Sexton,Alice Yu,Philippe E. Spiess,Logan W. Zemp,Scott Michael Gilbert,Brandon J. Manley,Vivien Yin,Rohit Jain,Javier F. Torres–Roca,Peter A.S. Johnstone
标识
DOI:10.1097/ju.0000000000004849
摘要
PURPOSE: Radical cystectomy and trimodality therapy (TMT) are efficacious treatments for muscle invasive bladder cancer. Novel methods for post-treatment surveillance are needed to detect recurrence. This study assesses the value of plasma circulating tumor DNA (ctDNA) for detection of post-TMT recurrence. MATERIALS AND METHODS: We performed a retrospective ctDNA analysis in 32 patients with at least one post-TMT ctDNA measurement before any disease recurrence. Patients were stratified as post-TMT ctDNA (+) or ctDNA (-) and assessed for metastasis-free survival and recurrence-free survival (RFS) using Kaplan-Meier and Cox regression methods. RESULTS: = .03). CONCLUSIONS: Plasma ctDNA is a potential biomarker for early detection of metastatic progression after TMT. Our hypothesis-generating findings provide a basis for larger studies to evaluate the utility of ctDNA-guided post-TMT surveillance.
科研通智能强力驱动
Strongly Powered by AbleSci AI